BMC Cancer

Table 1 Clinicopathologic features for patients suffering SCLC (n = 60)

From: Transcription factor E2F1 promotes EMT by regulating ZEB2 in small cell lung cancer

Variables		N (%)	Statistical analysis
Variables		N (%)	HR	95%CI	P
Age	<60	16(26.67)	1	0.297–1.558	0.362
Age	≥ 60	44(73.33)	0.681	0.297–1.558	0.362
Gender	Male	55(91.67)	1	0.900–8.409	0.076
Gender	Female	5(8.33)	2.752	0.900–8.409	0.076
Smoking	Non-smoker	4(6.67)	1	0.603–4.697	0.321
Smoking	Smoker	56(93.33)	1.682	0.603–4.697	0.321
Tumor size	< 4 cm	24(40.00)	1	0.344–1.397	0.306
Tumor size	≥ 4 cm	36(60.00)	0.693	0.344–1.397	0.306
Clinical stage	Limited disease	8(13.33)	1	0.072–0.831	0.024
Clinical stage	Extensive disease	52(86.67)	0.224	0.072–0.831	0.024

*represents p<0.05

Back to article page

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com